Skip to main content
. 2020 Mar 7;9(3):724. doi: 10.3390/jcm9030724

Figure 2.

Figure 2

In total, 207 patients were included in the study. Among them, 181 patients in cohort A with confirmed QM and non-QM tumors served as the training and cross-validation data, and 45 patients in cohort B with unclassifiable tumors were used for model testing.